141 related articles for article (PubMed ID: 11758875)
1. Anemia treatment and the radiation oncologist: optimizing patient outcomes.
Shasha D; Harrison LB
Oncology (Williston Park); 2001 Nov; 15(11):1486-91; discussion 1494-6. PubMed ID: 11758875
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence.
Crawford J
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):41-53. PubMed ID: 12380954
[TBL] [Abstract][Full Text] [Related]
3. Management of anemia in patients undergoing curative radiotherapy. Erythropoietin, transfusions, or better nothing?
Dunst J
Strahlenther Onkol; 2004 Nov; 180(11):671-81. PubMed ID: 15549184
[TBL] [Abstract][Full Text] [Related]
4. Anemia in cancer patients: significance, epidemiology, and current therapy.
Tchekmedyian NS
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):17-24. PubMed ID: 12380951
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin in radiation oncology - A review. 1st international conference, Freiburg, June 11-12, 1999.
Henke M; Guttenberger R
Oncology; 2000 Feb; 58(2):175-82. PubMed ID: 10705246
[TBL] [Abstract][Full Text] [Related]
6. Anemia in lung cancer: clinical impact and management.
Pirker R; Wiesenberger K; Pohl G; Minar W
Clin Lung Cancer; 2003 Sep; 5(2):90-7. PubMed ID: 14596691
[TBL] [Abstract][Full Text] [Related]
7. The blue cross blue shield assessment technology review: summary of findings.
Bennett CL
Best Pract Res Clin Haematol; 2005; 18(3):423-31. PubMed ID: 15792916
[TBL] [Abstract][Full Text] [Related]
8. Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy.
Shasha D; George MJ; Harrison LB
Cancer; 2003 Sep; 98(5):1072-9. PubMed ID: 12942577
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia.
Vaupel P; Dunst J; Engert A; Fandrey J; Feyer P; Freund M; Jelkmann W
Onkologie; 2005 Apr; 28(4):216-21. PubMed ID: 15840971
[TBL] [Abstract][Full Text] [Related]
10. [Updating 1999 of Standards, Options and Recommendations (SOR) for the clinical use of erythropoietin in oncology. FEDERATION OF THE FRENCH CANCER CENTRES (FNCLCC)].
Spaëth D; Marchal C; Bataillard A; Blanc-Vincent MP
Bull Cancer; 1999; 86(7-8):631-9. PubMed ID: 10477381
[TBL] [Abstract][Full Text] [Related]
11. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
Voravud N; Sriuranpong V; Suwanrusme H
J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
[TBL] [Abstract][Full Text] [Related]
12. Phase III clinical trials with darbepoetin: implications for clinicians.
Glaspy J
Best Pract Res Clin Haematol; 2005; 18(3):407-16. PubMed ID: 15792914
[TBL] [Abstract][Full Text] [Related]
13. Standard of care for cancer-related anemia: improving hemoglobin levels and quality of life.
Cortesi E; Gascón P; Henry D; Littlewood T; Milroy R; Pronzato P; Reinhardt U; Shasha D; Thatcher N; Wilkinson P
Oncology; 2005; 68 Suppl 1():22-32. PubMed ID: 15855813
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of anemia and role of erythropoietin in radiation therapy.
Smaniotto D; Luzi S; Morganti AG; Cellini N
Tumori; 2000; 86(1):17-23. PubMed ID: 10778761
[TBL] [Abstract][Full Text] [Related]
15. Practitioners' practical model for managing cancer-related anemia.
Smith RE; Tchekmedyian S
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):55-63. PubMed ID: 12380955
[TBL] [Abstract][Full Text] [Related]
16. Treatment of anemia with darbepoetin alfa in the radiation oncology setting.
Finney D; Allison RR
J Support Oncol; 2005; 3(6 Suppl 4):6-7. PubMed ID: 16355547
[No Abstract] [Full Text] [Related]
17. rHuEPO and treatment outcomes: the clinical experience.
Hudis CA; Van Belle S; Chang J; Muenstedt K
Oncologist; 2004; 9 Suppl 5():55-69. PubMed ID: 15591423
[TBL] [Abstract][Full Text] [Related]
18. [Anemia impact on treatments of cervical carcinomas].
Marchal C; Rangeard L; Brunaud C
Cancer Radiother; 2005 Mar; 9(2):87-95. PubMed ID: 15820436
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy-associated anemia: the scope of the problem.
Harrison LB; Shasha D; White C; Ramdeen B
Oncologist; 2000; 5 Suppl 2():1-7. PubMed ID: 10896322
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin β: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients.
Durmaz O; Demirkaya M; Sevinir B
Pediatr Hematol Oncol; 2011 Sep; 28(6):461-8. PubMed ID: 21707225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
